Page 2489 - Williams Hematology ( PDFDrive )
P. 2489

2460           Index                                                                                                                                                                                               Index         2461




               Lymphocytes, disorders (Cont.):         pertussis, 1202                    Hodgkin lymphoma treatment and, 1617
                   combined T-and B-cell, 1197         stress lymphocytosis, 1204         indolent, 1501t, 1570
                   natural killer cell, 1197        Lymphoid fibrosis, 1553. See also Hairy cell   marrow findings, 31–32
                   T lymphocyte, 1195–1197                 leukemia (HCL)                 monocytosis and, 1097
                 infants, 108–109, 109t             Lymphoid-myeloid primed progenitor    in pregnancy, 124
                 infusions from donor, in allogenic        (LMPP), 61, 1152f, 1153        response assessment, 1570, 1578–1579,
                       hematopoietic cell transplantation,   Lymphoid progenitors, 269–270     1579t, 1580t
                       359, 373                       functional characterization, 1154   secondary acute myelogenous leukemia
                 large granular, 23                   human, 1153                              and, 1407
                 marrow, 32t, 35                      murine, 1153                        staging, 1570, 1577–1579, 1577f, 1578t,
                 in mycosis fungoides, 1683f          thymic, 1154                             1579t
                 in myelodysplastic syndromes, 1353  Lymphoid tissues, 85                 vaccine therapy for, 423, 423f, 424f
                 in newborn, 105t                     lymph nodes. See Lymph nodes      Lymphomatoid granulomatosis, 1635
                 precursors, increased apoptosis of, 1217  mucosa-associated, 93–94     Lymphomatoid papulosis, 1499t, 1688–1689,
                 reactive, 23                         Peyer patches, 94, 94f                   1688t
                 reference ranges, 15t, 18t           spleen. See Spleen                Lymphomatous polyposis, 1593, 1593f
                 release, 72                          thymus. See Thymus                Lymphopenia, consultative approach to, 42
                 structure, 1137–1140                 tonsils, 94, 1081f                Lymphoplasmacytic lymphoma (LPL).
                   changes associated with activation,   Lymphokines, 208–209                  See also Waldenström
                       1138f, 1139–1140, 1140f      Lymphomas, 1569–1583. See also individual   macroglobulinemia (WM)
                   cytomatrix, 1144–1145                   types                          chromosomal abnormalities, 184t, 1494t
                   definition and history, 1137       aggressive, 1501t                   definition, 1785
                   microscopy and histochemistry, 966f,   cell growth and metabolism in, 199–200  differential diagnosis, 1667, 1668
                       1137–1139, 1138f, 1139f        chromosomal abnormalities, 184–185t,   gene mutations, 184t, 234t, 1494t
                   organelles, 1145                        187–188, 224–225t, 1576–1577   laboratory features, 1592–1593, 1593f
                   types, 20f, 23                     vs. chronic lymphocytic leukemia, 1543  Lymphopoiesis, 1149–1156, 1282f
               Lymphocytic choriomeningitis virus     classification, 1493–1501, 1587–1589,   differentiation pathways, 1151–1154, 1152f
                       (LCMV), 1192                        1588t                            functional characterization of
               Lymphocytopenia, 1204–1206             clinical features, 1493, 1577            progenitors in, 74.
                 acquired, 1204–1206, 1205t            abnormal immunoglobulin production,   human lymphoid progenitors in, 1153
                   iatrogenic, 1205–1206                   1501                             murine lymphoid progenitors in, 1153
                   in infectious diseases, 1204–1205   lymphokine-induced disorders, 1502   thymic progenitors in, 1154
                   nutritional or dietary, 1206        marrow and tissue infiltration, 1502  fetal, 101
                   in systemic disease, 1206           metabolic signs, 1502              neonatal, 108–109
                 definition, 1204                      systemic symptoms, 1502            during prenatal development, 1149–1151,
                 idiopathic CD4+ T, 1206              definition and history, 1569–1570        1150f
                 inherited causes, 1204, 1205t        diagnosis, 1590–1592, 1591t         regulation, 1154–1156
               Lymphocytosis, 1199–1204               early precursor lesions, 1501     Lymphosarcoma, 1569, 1603
                 causes, 1200t                        epidemiology, 1570–1571, 1570f, 1571f  Lyso-glucosylsphingosine, 1126
                 consultative approach to, 44         etiology and pathogenesis, 1571–1576  Lysophosphatidic acid (LPA), 1878
                 definition, 1199                      autoimmunity, 1574–1575          Lysosomal granule constituents, 286t, 287
                 primary, 1199–1202                    environmental factors, 1571, 1572–1573  Lysosomal proteases, 284t
                   monoclonal B-cell lymphocytosis,    histopathologic heterogeneity,    Lysosomal storage diseases. See Lipid storage
                       1199–1200, 1201t, 1542–1543         1571–1572, 1572t                    diseases
                   persistent polyclonal lymphocytosis of B   immunosuppression, 1574, 1575t  Lysosome-associated membrane proteins. See
                       lymphocytes, 1200–1202, 1201f   infectious agents, 1265, 1573–1574      under LAMP
                 secondary (reactive), 1202–1204       interaction of environment and   Lysosomes, 1145, 1843
                   acute infection lymphocytosis, 1202,    genotype, 1573               Lysozyme, 284t, 1012t, 1014, 1064, 1067t
                       1203f                          extranodal involvement, 1502      LYST, 994, 1229, 1843
                   drug-induced lymphocytosis,        gene mutations, 166, 209–210      Lytic state, 403
                       1203–1204                      hematopoietic cell transplantation for, 366
                   hypersensitivity reactions, 1204   histologic subtypes and frequency of,   M
                   infectious mononucleosis, 1202          1571–1572, 1572t             mAbs. See Monoclonal antibodies (mAbs)
                   large granular lymphocytosis,      HIV-associated. See Human         MAC, 234t
                       1202–1203                           immunodeficiency virus       MAC (membrane attack complex), 572, 572f
                   persistent lymphocytosis, 1204          (HIV)–associated malignancies  Mac-1. See CD11b/CD18 (Mac-1)








          Kaushansky_index_p2393-2506.indd   2460                                                                       9/21/15   3:22 PM
   2484   2485   2486   2487   2488   2489   2490   2491   2492   2493   2494